From 2011 to 2018, families who said they had difficulty with medical expenses in the past year dropped from 19.7 percent to 14.2 percent, according to the CDC’s National Center for Health Statistics.
Category: Forbes
Religious Leaders Can Help Build Vaccine Confidence
religion may be getting used as a justification for anti-vaxx beliefs, not necessarily as the source of them
COVID-19: Why Names Of New Infectious Diseases Matter
In 2015, long before the current epidemic involving COVID-19, the WHO issued best practice guidelines for scientists, health authorities, and the media to follow in naming new infectious diseases to minimize what it called “unnecessary negative effects…
CVS Health Hubs Target Aetna Members As Rollout Escalates
CVS Health’s strategy to reformat hundreds of drugstores into “HealthHubs” is to first integrate new healthcare options in markets where there are Aetna health plan members.
There’s Been A Sharp Rise In Coronavirus Cases—Here’s What’s Behind It
China saw its deadliest day from the coronavirus on Wednesday, in the same week that Chinese health officials predicted that the pneumonia-like virus was nearing its peak.
COVID-19: Would A Coronavirus By Any Other Name Seem Less Scary?
The name had to be pronounceable and descriptive but not “refer to a geographical location, an animal, an individual or group of people,” according to the World Health Organization.
New Coronavirus, COVID-19, Counting Method Leads To Jump In Cases, Deaths
Yesterday sounded like the worst day yet for the new coronavirus or COVID-19 outbreak. But here are the caveats.
Cases Of COVID-19 Soar On Quarantined Coronavirus Cruise Ship. 218 Now Affected.
44 new cases of COVID-19 confirmed on stricken cruise ship as the quarantine tactics employed by Japanese authorities continue to fail those on board.
Apple Watch Wrist Pain? How I Cured Mine Literally Overnight
I love my Apple Watch. But, it has been giving me wrist pain.
Testing For COVID-19 In All Patients With Unexplained Pneumonia Is Probably Not Cost-Effective
At this point, is more widespread testing of all patients with unexplained pneumonia (even those who haven’t been to China) warranted from a societal cost-effectiveness perspective? It’s a question that needs to be asked.
